Form 4: Axogen Director Joseph A. Tyndall Reports Stock Vesting

Director Joseph A. Tyndall reports the vesting of 11,904 restricted stock units into common stock on September 1, 2024.

Summary

• Joseph A. Tyndall, a director of Axogen, Inc., reported a transaction on September 1, 2024.
• The transaction involved the vesting of 11,904 restricted stock units, which converted into common stock.
• These restricted stock units were part of an annual equity grant for service as a Director on the Axogen, Inc. Board of Directors.
• The grant was valued at $150,000 as of the grant date and vested on September 1, 2024, the one-year anniversary of the grant date.
• Following the transaction, Tyndall directly owns 22,557 shares of Axogen common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to stock vesting, which is neither particularly positive nor negative.

Positives

• The vesting of restricted stock units indicates continued service and commitment by a director to the company.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can influence investor sentiment.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding director compensation and stock ownership.

Key Dates